Brcapro software programs code#
Brcapro software programs professional#

Brcapro software programs professional#

American College of Medical Genetics Professional Practice and Guidelines Committee. 2004 22:735-42. Crossref Medline Google Scholar Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature. The concise handbook of family cancer syndromes. 2001 37:1904-9. Crossref Medline Google Scholar A founder mutation of the BRCA1 gene in Western Sweden associated with a high incidence of breast and ovarian cancer. Einbeigi Z, Bergman A, Kindblom LG, Martinsson T, Meis-Kindblom JM, Nordling M, et al. 1998 35:446-9. Crossref Medline Google Scholar A population study of mutations and LOH at breast cancer gene loci in tumours from sister pairs: two recurrent mutations seem to account for all BRCA1/BRCA2 linked breast cancer in Iceland. Arason A, Jonasdottir A, Barkardottir RB, Bergthorsson JT, Teare MD, Easton DF, et al. 1996 13:117-9. Crossref Medline Google Scholar A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Thorlacius S, Olafsdottir G, Tryggvadottir L, Neuhausen S, Jonasson JG, Tavtigian SV, et al. A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families.

Peelen T, vanVliet M, Petrij-Bosch A, Mieremet R, Szabo C, van den Ouweland AM, et al. 1996 13:126-8. Crossref Medline Google Scholar Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Neuhausen S, Gilewski T, Norton L, Tran T, McGuire P, Swensen J, et al. 1996 14:185-7. Crossref Medline Google Scholar Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, et al. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Easton DF, Bishop DT, Ford D, Crockford GP. 1994 343:692-5. Crossref Medline Google Scholar Risks of cancer in BRCA1-mutation carriers. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE. 1995 72:805-12. Crossref Medline Google Scholar The genetics of breast and ovarian cancer. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Cancer incidence in BRCA1 mutation carriers. Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. Brose MS, Rebbeck TR, Calzone KA, Stopfer JE, Nathanson KL, Weber BL. Identification of the breast cancer susceptibility gene BRCA2. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, et al. 1994 266:66-71. Crossref Medline Google Scholar A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, et al.

Harris: Kaiser Permanente Center for Health Research, 3800 North Interstate Avenue, Portland, OR 97227.

Brcapro software programs code#

Fu: Oregon Health & Science University, Mail Code CB 669, 3181 SW Sam Jackson Park Road, Portland, OR 97239.ĭr. Hoyt Huffman: Oregon Health & Science University, Mail Code BICC, 3181 Southwest Sam Jackson Park Road, Portland, OR 97239.ĭr. Nelson, MD, MPH, Oregon Health & Science University, Mail Code BICC 504, 3181 Southwest Sam Jackson Park Road, Portland, OR 97239 e-mail, edu.Ĭurrent Author Addresses: Dr. 2, Rockville, Maryland.Ĭorresponding Author: Heidi D. Grant Support: This study was conducted by the Oregon Evidence-based Practice Center under contract to the Agency for Healthcare Research and Quality, contract 290-02-0024, Task Order no. From Oregon Health & Science University and Kaiser Permanente Center for Health Research, Portland, Oregon.Īcknowledgments: The authors thank Miranda Walker, BA Christina Bougatsos, BS Andrew Hamilton, MLS, MS Mark Helfand, MD, MPH Wylie Burke, MD, PhD Gurvaneet Randhawa, MD, MPH members of the USPSTF and reviewers for their contributions to this project.